MCRB EV/EBITDA
-3.14
-0.48-18.05%
Thu, 23 Jan 2025 00:55:55 GMT
Summary:
As of January 23, 2025, MCRB EV/EBITDA is -3.14, with a fall of -0.48 (-18.05%) during the most recent trading day. Over the past year, it has increased by +135.14 (+97.73%). MCRB EV/EBITDA is now -135.36% below its all-time high of 8.88.MCRB EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MCRB EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -18.1% |
| 1 m1 month | +3.7% |
| 3 m3 months | -13.8% |
| 6 m6 months | +54.4% |
| ytdytd | -8.7% |
| 1 y1 year | +97.7% |
| 5 y5 years | +11.8% |
MCRB EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -2.65 | -18.5% | -3.33 | +5.7% |
| 3 m | 3-month | -2.14 | -46.7% | -3.33 | +5.7% |
| 6 m | 6-month | -2.14 | -46.7% | -7.59 | +58.6% |
| 1 y | 1-year | 8.88 | -135.4% | -144.30 | +97.8% |
| 3 y | 3-year | 8.88 | -135.4% | -160.04 | +98.0% |
| 5 y | 5-year | 8.88 | -135.4% | -160.04 | +98.0% |
| alltime | all time | 8.88 | -135.4% | -160.04 | +98.0% |
Seres Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -3.14(+8.7%) |
| 2024 | -2.89(-98.1%) |
| 2023 | -149.16(+4990.8%) |
| 2022 | -2.93(-73.8%) |
| 2021 | -11.19(-58.9%) |
| Date | Value |
|---|---|
| 2020 | -27.20(+664.0%) |
| 2019 | -3.56(+226.6%) |
| 2018 | -1.09(-76.1%) |
| 2017 | -4.57(+17.5%) |
| 2016 | -3.89(-83.8%) |
| 2015 | -23.97 |
FAQ
- What is Seres Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Seres Therapeutics?
- What is MCRB EV/EBITDA year-to-date change?
- What is Seres Therapeutics EV/EBITDA year-on-year change?
What is Seres Therapeutics EV/EBITDA?
The current EV/EBITDA of MCRB is -3.14
What is the all time high EV/EBITDA for Seres Therapeutics?
Seres Therapeutics all-time high EV/EBITDA is 8.88
What is MCRB EV/EBITDA year-to-date change?
Seres Therapeutics EV/EBITDA has changed by -0.25 (-8.65%) since the beginning of the year
What is Seres Therapeutics EV/EBITDA year-on-year change?
Over the past year, MCRB EV/EBITDA has changed by +135.14 (+97.73%)